The co-expression assay between immunocytes and clinical prognosis revealed that the fractions of M1 macrophages, resting dendritic cells, regulatory T cells (Tregs), and memory CD4+ T cells significantly differed among different cancer grades (Figures 7A-E). Here, CD4 is linked to cancer.